4//SEC Filing
McDowell Caryn Gordon 4
Accession 0001479290-19-000071
CIK 0001479290other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 8:30 PM ET
Size
5.1 KB
Accession
0001479290-19-000071
Insider Transaction Report
Form 4
McDowell Caryn Gordon
SVP, GC & Secretary
Transactions
- Tax Payment
Common Stock
2019-06-15$10.86/sh−1,383$15,019→ 22,935 total
Footnotes (2)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on June 15, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock award ("RSA") for 16,000 shares. The RSA vests in four equal annual installments from June 15, 2018, subject to Ms. McDowell's Continuous Service (as defined in the Issuer's 2014 Inducement Plan (the Plan)) on each vesting date.
- [F2]The fair market value was determined on June 14, 2019, pursuant to the Plan.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001674232
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 8:30 PM ET
- Size
- 5.1 KB